Automated Central System Offers Time Savings for Pharmacists

Share this content:
Automated Central System Offers Time Savings for Pharmacists
Automated Central System Offers Time Savings for Pharmacists

FRIDAY, Feb. 16, 2018 (HealthDay News) -- An automated central pharmacy system, Omnicell XR2, is helping pharmacists save time, allowing them to take on additional roles as part of a transition-of-care team, according to a report published in Drug Topics.

The cart-fill process using the new automated system is more efficient and frees up time for pharmacists. One of the advantages of the automated system is that it is model-agnostic and can work in a decentralized model using primarily automated dispensing cabinets on the floors, or in a more cart-fill-centric operation. The XR2 uses the same platform for either of these models.

Noting that many health system pharmacists have become involved with transition-of-care initiatives, in addition to their traditional role of order verification, order checking, and dispensing the product to the unit, the new technology is helping to save time for pharmacists. Use of the technology at the Summa Health System-Barberton Campus in Ohio has been beneficial, saving time for pharmacists and technicians even though the amount of time savings has not been fully realized as use of the technology is in early phases.

"It is really helping to improve the patient medication experience by helping to get pharmacy more engaged in the clinical process," Betsy Martinelli, Senior Manager for Corporate Marketing at Omnicell, said in a statement.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »